drugset / Trial / NCT03751228

A Taste Assessment of BMS-986165 in Healthy Participants

NCT03751228

Phase 1 Completed 9 enrolled Bristol-Myers Squibb
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the taste characteristics of BMS-986165 formulations, alone and mixed, in order to develop a pediatric oral form of BMS-986165.

Timeline

Start
2018-10-11
Primary completion
2018-11-26
Completion
2018-11-26

Drugs

EvaluationDrugModalityDoseRoute
Subject CRAVACITINIB Small molecule Other

Indications

No indication recorded.